Vickie S. Reed - 24 May 2022 Form 4 Insider Report for Adamis Pharmaceuticals Corp

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 24 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2022, 16:19:03 UTC
Prior SEC filing: 28 Apr 2022
Next SEC filing: 11 May 2023
Source filing: View source filing
Reporting owner signature: /s/ David C. Benedicto, as Attorney-in-Fact

Key filing fact

Vickie S. Reed filed Form 4 for Adamis Pharmaceuticals Corp on 26 May 2022.

Key facts

This page summarizes Vickie S. Reed's Form 4 filing for Adamis Pharmaceuticals Corp.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 May 2022, 16:19.

Change

Previous filing in this sequence was filed on 28 Apr 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ADMP transaction Derivative

Stock Appreciation Right

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 24 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $0.4100
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Stock Appreciation Right can only be settled in cash.

Footnote F2

The Stock Appreciation Right ("SAR") will vest with respect to 1/6 of the shares subject to the SAR on the six-month anniversary of the date of grant, and thereafter with respect to 1/36 of the shares on each monthly anniversary of the date of grant with all remaining unvested shares subject to the SAR vesting on the thirty-sixth (36th) monthly anniversary of the date of grant.

SEC remarks

* Exhibit 24 - Power of Attorney.